Automated insulin delivery in women with type 1 diabetes during the peripartum period: Maintaining autonomy while optimizing care – review and clinical evaluation

In type 1 diabetes, optimal glucose management during the peripartum period is critical to reduce neonatal hypoglycemia shortly after birth as well as maternal hypoglycemia postpartum when insulin requirements fall quickly. Healthcare professionals and their patients must consider the mode of insulin delivery during the peripartum period, meaning either to keep a person's own subcutaneous insulin delivery mode- including automated insulin delivery (AID) systems - or to switch to an intravenous insulin/glucose infusion. In this article, we review continuation of AID systems during the peripartum period in women with type 1 diabetes. We included data from local and (inter)national guidelines, evidence from recent publications, and combined this with data from our own clinic. We recommend continuing an AID system over switching to manual mode or an insulin/glucose infusion, provided this is preferred by the patient and several basic criteria are fulfilled.